The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of previously unrecognized germline p53 mutations in Li-Fraumeni syndrome patients through retesting of archival DNA samples.
A. Novokmet
No relevant relationships to disclose
B. Baskin
No relevant relationships to disclose
D. Malkin
No relevant relationships to disclose